187
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Impact of Supporting People with Advanced Parkinson’s Disease on Carer’s Quality of Life and Burden

ORCID Icon, ORCID Icon, , , , ORCID Icon, , ORCID Icon, , , , , , ORCID Icon & ORCID Icon show all
Pages 2899-2912 | Published online: 02 Dec 2020

References

  • Bhimani R. Understanding the burden on caregivers of people with Parkinson’s: a scoping review of the literature. Rehabil Res Pract. 2014;718527. doi:10.1155/2014/718527
  • Mosley PE, Moodie R, Dissanayaka N. Caregiver burden in parkinson disease: a critical review of recent literature. J Geriatr Psychiatry Neurol. 2017;30(5):235–252.28743212
  • Martínez-Martín P, Forjaz MJ, Frades-Payo B, et al. Caregiver burden in parkinson’s disease. Mov Dis. 2007;22(7):924–931. doi:10.1002/mds.21355
  • Santos-García D 1, de la Fuente-fernández R. Factors contributing to caregivers’ stress and burden in parkinson’s disease. Acta Neurol Scand. 2015;131(4):203–210. doi:10.1111/ane.1230525212106
  • Schrag A, Hovris A, Moreley D, et al. Caregiver-burden in parkinson’s disease is closely associated with psychiatric symptoms, falls, and disability. Parkins Rel Disord. 2006;12:35–41. doi:10.1016/j.parkreldis.2005.06.011
  • Oh YS, Lee JE, Lee PH, et al. Neuropsychiatric symptoms in parkinson’s disease dementia are associated with increased caregiver burden. J Mov Disord. 2015;8:26–32. doi:10.14802/jmd.1401925614783
  • Sensi M, Cossu G, Mancini F, et al. On behalf of the Italian Levodopa Carbidopa Intestinal Gel Working Group. Which patients discontinue? Issues on levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up. Parkins Rel Disord. 2017;38:90–92. doi:10.1016/j.parkreldis.2017.02.020
  • Greenwell K, Gray WK, van Wersch A, van Schaik P, Walker R. Predictors of the psychosocial impact of being a carer of people living with parkinson’s disease: a systematic review. Parkins Rel Disord. 2015;21(1):1–11. doi:10.1016/j.parkreldis.2014.10.013
  • Rektorova I. Current treatment of behavioral and cognitive symptoms of parkinson’s disease. Parkins Rel Disord. 2019;59:65–73. doi:10.1016/j.parkreldis.2019.02.042
  • Torny F, Videaud H, Chatainier P, Tarrade C, Meissner WG, Couratier P. Factors associated with spousal burden in parkinson’s disease. Rev Neurol. 2018;174(10):711–715. doi:10.1016/j.neurol.2018.01.37230032927
  • Martinez-Martin P, Rodriguez-Blazquez C, Forjaz MJ. Quality of life and burden in caregivers for patients with parkinson’s disease: concepts, assessment and related factors. Expert Rev Pharmacoecon Outcomes Res. 2012;12:221–230. doi:10.1586/erp.11.10622458623
  • Dickens CM, McGowan L, Percival C. Lack of a close confidant, but not depression, predicts further cardiac events after myocardial infarction. Heart. 2004;90(5):518–522. doi:10.1136/hrt.2003.01166815084548
  • Benavides O, Alburquerque D, Chaná-Cuevas P. Burden among caregivers of patients with parkinson disease. Rev Med Chil. 2013;141(3):320–326. doi:10.4067/S0034-9887201300030000623900322
  • Lökk J. Caregiver strain in parkinson’s disease and the impact of disease duration. Eur J Phys Rehabil Med. 2008;44(1):39–45.18385627
  • Antonini A, Nitu B. Apomorphine and levodopa infusion for motor fluctuations and dyskinesia in advanced parkinson disease. J Neural Transm. 2018;125(8):1131–1135. doi:10.1007/s00702-018-1906-030006821
  • Lewis CJ, Maier F, Horstkötter N, et al. The impact of subthalamic deep brain stimulation on caregivers of parkinson’s disease patients: an exploratory study. J Neurol. 2015;262(2):337–345. doi:10.1007/s00415-014-7571-925381461
  • Ciurleo R, Corallo F, Bonanno L, et al. Assessment of duodopa® effects on quality of life of patients with advanced parkinson’s disease and their caregivers. J Neurol. 2018;265(9):2005–2014. doi:10.1007/s00415-018-8951-329951701
  • Tessitore A, Marano P, Modugno N, et al. Caregiver burden and its related factors in advanced parkinson’s disease: data from the PREDICT study. J Neurol. 2018;265(5):1124–1137. doi:10.1007/s00415-018-8816-929516169
  • Mosley PE, Breakspear M, Coyne T, Silburn P, Smith D. Caregiver burden and caregiver appraisal of psychiatric symptoms are not modulated by subthalamic deep brain stimulation for parkinson’s disease. NPJ Parkinsons Dis. 2018;4:12. doi:10.1038/s41531-018-0048-229675463
  • Soileau MJ, Persad C, Taylor J, Patil PG, Chou KL. Caregiver burden in patients with parkinson disease undergoing deep brain stimulation: an exploratory analysis. J Parkinsons Dis. 2014;4(3):517–521. doi:10.3233/JPD-14038024903924
  • Crespo-Burillo JA, Rivero-Celada D, Saenz-de Cabezón A, Casado-Pellejero J, Alberdi-Viñas J, Alarcia-Alejos R. Deep brain stimulation for patients with parkinson’s disease: effect on caregiver burden. Neurologia. 2018;33(3):154–159. doi:10.1016/j.nrl.2016.05.01727443241
  • Chattat R, Cortesi V, Izzicupo F, et al. The Italian version of the zarit burden interview: a validation study. Int Psychogeriatrics. 2011;23:797–805. doi:10.1017/S1041610210002218
  • Peto V, Jenksinson C, Fitzpatrick R. PDQ-39: a review of the development, validation and application of a parkinson’s disease quality of life questionnaire and its associated measures. J Neurol. 1998;245:S10–S14.9617716
  • Glozman JM, Bicheva KG, Fedorova NV. Scale of Quality of Life of Care-Givers (SQLC). J Neurol. 1998;245(Suppl S1):S39–S41. doi:10.1007/PL000077389617723
  • Martinez M, Multani N, Anor CJ, et al. Emotion detection deficits and decreased empathy in patients with alzheimer’s disease and parkinson’s disease affect caregiver mood and burden. Front Aging Neurosci. 2018;10:120. doi:10.3389/fnagi.2018.0012029740312
  • Martinez-Martin P, Rodriguez-Blazquez C, Forjaz MJ, et al. Neuropsychiatric symptoms and caregiver’s burden in Parkinson’s disease. Parkins Rel Disord. 2015;21(6):629–634. doi:10.1016/j.parkreldis.2015.03.024
  • Grün D, Pieri V, Vaillant M, Diederich NJ. Contributory factors to caregiver burden in parkinson disease. J Am Med Dir Assoc. 2016;17(7):626–632. doi:10.1016/j.jamda.2016.03.00427143237
  • Bartolomei L, Pastore A, Meligrana L, et al. Relevance of sleep quality on caregiver burden in parkinson’s disease. Neurol Sci. 2018;39(5):835–839.29445989
  • Lau KM, Au A. Correlates of informal caregiver distress in parkinson’s disease: a meta-analysis. Clin Gerontol. 2011;34:117–131. doi:10.1080/07317115.2011.539521
  • Pinquart M, Sörensen S. Associations of stressors and uplifts of caregiving with caregiver burden and depressive mood: a meta-analysis. J Gerontol B Psychol Sci SocSci. 2003;58(2):P112–P128.
  • Ozdilek B, Gunal DI. Motor and non-motor symptoms in Turkish patients with parkinson’s disease affecting family caregiver burden and quality of life. J Neuropsychiatry Clin Neurosci. 2012;24:478–483. doi:10.1176/appi.neuropsych.1110031523224455
  • Vatter S, McDonald KR, Stanmore E, Clare L, Leroi I. Multidimensional care burden in parkinson-related dementia. J Geriatr Psychiatry Neurol. 2018;31(6):319–328. doi:10.1177/089198871880210430244631
  • Leroi I, McDonald K, Pantula H, Harbishettar V. Cognitive impairment in parkinson disease: impact on quality of life, disability, and caregiver burden. J Geriatr Psychiatry Neurol. 2012;25(4):208–214. doi:10.1177/089198871246482323172765
  • Zarit SH, Zarit JM; 1983. Available from: www.mapi-trust.org, https://eprovide.mapi-trust.org/. Accessed November 25, 2020.